• 1
    Fujita T, Chan JCM, Bartter FC. Effects of oral furosemide and salt loading on parathyroid function in normal subjects. Nephron 1984; 38: 10914.
  • 2
    Reichel H, Deibert B, Geberth S, Schmidt GH, Ritz E. Furosemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant 1992; 7: 815.
  • 3
    Coe FL, Canterbury JM, Firpo JJ, Reiss E. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria. J Clin Invest 1973; 52: 13442.
  • 4
    Rejnmark L, Vestergaard P, Pedersen AR, Heickendorff L, Andreasen F, Mosekilde L. Dose-effect relations of loop- and thiazide-diuretics on calcium homeostasis: a randomized, double-blinded Latin-square multiple cross-over study in postmenopausal osteopenic women. Eur J Clin Invest 2003; 33: 4150.
  • 5
    Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover. J Intern Med 2005; 257: 17684.
  • 6
    Ooms ME, Lips P, Van Lingen A, Valkenburg HA. Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women. J Bone Miner Res 1993; 8: 66975.
  • 7
    Heidrich FE, Stergachis A, Gross KM. Diuretic drug use and the risk for hip fracture. Ann Intern Med 1991; 115: 16.
  • 8
    Rashiq S, Logan RFA. Role of drugs in fractures of the femoral neck. BMJ 1986; 292: 8613.
  • 9
    Cumming RG, Klineberg RJ. Psychotropics, thiazide diuretics and hip fractures in the elderly. Med J Aust 1993; 158: 4147.
  • 10
    Frank L. Epidemiology. When an entire country is a cohort. Science 2000; 287: 23989.
  • 11
    Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999; 46: 2638.
  • 12
    Vestergaard P, Mosekilde L. Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 2002; 156: 110.
  • 13
    Wacholder S, McLaughlin JK, Silverman DT, Mandel JS. Selection of controls in case-control studies. I. Principles. Am J Epidemiol 1992; 135: 101928.
  • 14
    Nielsen GL, Sorensen HT, Zhou W, Steffensen FH, Olsen J. The pharmacoepidemiologic prescription database of North Jutland – a valid tool in pharmacoepidemiological research. Int J Risk Safety Med 1997; 10: 2035.
  • 15
    Capella D. Descriptive tools and analysis. In: DukesMNG, ed. Drug Utilization Studies: Methods and Uses. Copenhagen: WHO Regional Publications, 1993; 558.
  • 16
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 37383.
  • 17
    de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003; 56: 2219.
  • 18
    Miettinen OS. Theoretical Epidemiology: Principles of Occurrence Research in Medicine. New York: Wiley & Sons, 1985.
  • 19
    Tromp AM, Ooms ME, Popp-Snijders C, Roos JC, Lips P. Predictors of fractures in elderly women. Osteoporos Int 2000; 11: 13440.
  • 20
    Steiniche T, Mosekilde L, Christensen MS, Melsen F. A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. APMIS 1989; 97: 30916.
  • 21
    Steiniche T, Mosekilde L, Christensen MS, Melsen F. Histomorphometric analysis of bone in idiopathic hypercalciuria before and after treatment with thiazide. APMIS 1989; 97: 3028.
  • 22
    Rejnmark L, Vestergaard P, Heickendorff L, Andreasen F, Mosekilde L. Loop diuretics alter the diurnal rhythm of endogenous parathyroid hormone secretion. A randomized-controlled study on the effects of loop- and thiazide-diuretics on the diurnal rhythms of calcitropic hormones and biochemical bone markers in postmenopausal women. Eur J Clin Invest 2001; 31: 76472.
  • 23
    Brater DC. Benefits and risks of torasemide in congestive heart failure and essential hypertension. Drug Saf 1996; 14: 10420.
  • 24
    Cumming RG, Miller JP, Kelsey JL et al. Medications and multiple falls in elderly people: the St Louis OASIS study. Age Ageing 1991; 20: 45561.
  • 25
    Xu JC, Lytle C, Zhu TT, Payne JA, Benz E Jr, Forbush B. Molecular cloning and functional expression of the bumetanide-sensitive Na-K-Cl cotransporter. Proc Natl Acad Sci U S A 1994; 91: 22015.
  • 26
    Puschett JB, Sylk D, Teredesai PR. Uncoupling of proximal sodium bicarbonate from sodium phosphate transport by bumetanide. Am J Physiol 1978; 235: F4038.
  • 27
    Khadeer MA, Tang Z, Tenenhouse HS et al. Na+-dependent phosphate transporters in the murine osteoclast: cellular distribution and protein interactions. Am J Physiol Cell Physiol 2003; 284: C163344.
  • 28
    Gupta A, Tenenhouse HS, Hoag HM et al. Identification of the type II Na(+)-Pi cotransporter (Npt2) in the osteoclast and the skeletal phenotype of Npt2-/- mice. Bone 2001; 29: 46776.
  • 29
    Hoidrup S, Gronbaek M, Gottschau A, Lauritzen JB, Schroll M. Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol 1999; 149: 9931001.